Organometallic Osmium Compounds in Cancer Therapy

[{“box”:0,”content”:”[if 992 equals=”Open Access”]

n

Open Access

n

[/if 992]n

n

Year : May 3, 2024 at 5:29 pm | [if 1553 equals=””] Volume :01 [else] Volume :01[/if 1553] | [if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] : 02 | Page : 01-25

n

n

n

n

n

n

By

n

    n t

    [foreach 286]n

    n

    A. Mohamed Sikkander, Rajeev Ranjan, A. Mohamed Sikkander

  1. [/foreach]

    n

n

n[if 2099 not_equal=”Yes”]n

    [foreach 286] [if 1175 not_equal=””]n t

  1. Associate Professor and Head, Assistant Professor, Associate professo, Department of Chemistry, Velammal Engineering College, Department of Chemistry, DSPM University, Department of Electronics & Telecommunication, Thakur College of Engineering, Chennai, Jharkhand, Maharashtra, India, India
  2. n[/if 1175][/foreach]

[/if 2099][if 2099 equals=”Yes”][/if 2099]nn

n

Abstract

nThe exploration of organometallic complexes with osmium as potential anticancer agents was indeed an area of ongoing research. These complexes were being investigated for their unique properties and mechanisms of action against cancer cells. However, it’s essential to note that the field of scientific research is dynamic, and new findings may have emerged since then. Organometallic complexes with osmium can be designed to exhibit specific features that make them promising candidates for anticancer applications. These features may include the ability to interact with cellular components, induce DNA damage, or modulate specific pathways crucial for cancer cell survival. To get the most current and accurate information on the latest developments in this field, I recommend checking recent scientific literature, research articles, and updates from reputable sources. Researchers often publish their findings in peer-reviewed journals, and these publications provide valuable insights into the progress of studies involving osmium-based organometallic complexes in cancer research and treatment. KP1339, also known as tetrachloride (dimethyl sulfoxide) (1H-indazole) ruthenate (III), is an osmium (III) compound that has been studied for its potential anticancer properties. It belongs to the class of organometallic compounds and has been investigated for its ability to induce cancer cell death and inhibit tumor growth. Osmium (II) arene complexes are a class of organometallic compounds that involve osmium in the +2-oxidation state coordinated with arene ligands. The structural characteristics and coordination environment of osmium (II) arene complexes make them interesting subjects of study for their potential applications, particularly in the field of medicinal chemistry and cancer research.

n

n

n

Keywords: Osmium (II) arene complexes, Osmium (III) compound, Cellular proteins, Induction of oxidative stress, Cancer cell replication

n[if 424 equals=”Regular Issue”][This article belongs to International Journal of Advance in Molecular Engineering(ijame)]

n

[/if 424][if 424 equals=”Special Issue”][This article belongs to Special Issue under section in International Journal of Advance in Molecular Engineering(ijame)][/if 424][if 424 equals=”Conference”]This article belongs to Conference [/if 424]

n

n

n

How to cite this article: A. Mohamed Sikkander, Rajeev Ranjan, A. Mohamed Sikkander.Organometallic Osmium Compounds in Cancer Therapy.International Journal of Advance in Molecular Engineering.April 20, 2024; 01(02):01-25.

n

How to cite this URL: A. Mohamed Sikkander, Rajeev Ranjan, A. Mohamed Sikkander , Organometallic Osmium Compounds in Cancer Therapy ijame April 20, 2024 {cited April 20, 2024};01:01-25. Available from: https://journals.stmjournals.com/ijame/article=April 20, 2024/view=0

n


n[if 992 equals=”Open Access”] Full Text PDF Download[/if 992] nn

n[if 379 not_equal=””]n

Browse Figures

n

n

[foreach 379]n

n[/foreach]n

nn

n

n[/if 379]n

n

References

n[if 1104 equals=””]n

nn[/if 1104][if 1104 not_equal=””]n

    [foreach 1102]n t

  1. [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]
  2. n[/foreach]

n[/if 1104]

nn


nn[if 1114 equals=”Yes”]n

n[/if 1114]

n

n

[if 424 not_equal=””]Regular Issue[else]Published[/if 424] Subscription Review Article

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n

n[if 2146 equals=”Yes”]

[/if 2146][if 2146 not_equal=”Yes”]

[/if 2146]n

n

n

Volume 01
[if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] 02
Received March 4, 2024
Accepted March 9, 2024
Published April 20, 2024

n

n

n

n

n

n

nn function myFunction2() {n var x = document.getElementById(“browsefigure”);n if (x.style.display === “block”) {n x.style.display = “none”;n }n else { x.style.display = “Block”; }n }n document.querySelector(“.prevBtn”).addEventListener(“click”, () => {n changeSlides(-1);n });n document.querySelector(“.nextBtn”).addEventListener(“click”, () => {n changeSlides(1);n });n var slideIndex = 1;n showSlides(slideIndex);n function changeSlides(n) {n showSlides((slideIndex += n));n }n function currentSlide(n) {n showSlides((slideIndex = n));n }n function showSlides(n) {n var i;n var slides = document.getElementsByClassName(“Slide”);n var dots = document.getElementsByClassName(“Navdot”);n if (n > slides.length) { slideIndex = 1; }n if (n (item.style.display = “none”));n Array.from(dots).forEach(n item => (item.className = item.className.replace(” selected”, “”))n );n slides[slideIndex – 1].style.display = “block”;n dots[slideIndex – 1].className += ” selected”;n }n”}]